N

NuCana plc
D

NCNA

1.05500
USD
0.11
(11.05%)
مغلق
حجم التداول
100
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
4,141,086
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALT
    -0.19000
    (-2.87%)
    6.42000 USD
    A
    AQST
    -0.05000
    (-1.63%)
    3.01500 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    E
    EBS
    -0.12000
    (-1.53%)
    7.72000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    V
    VXRT
    0.00670
    (0.95%)
    0.70980 USD
    المزيد
الأخبار
المقالات

العنوان: NuCana plc

القطاع: Healthcare
الصناعة: Biotechnology
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.